Senior Manager, SRHR - Innovative Financing

The Children's Investment Fund Foundation; Greater London; Sur place; GBP 120 000 - 180 000; Plein temps

Résumé du poste

The Children's Investment Fund Foundation invites applications for a Senior Manager, SRHR - HIV, TB and Innovative Financing. You will lead a portfolio of catalytic investments to improve access, affordability, and supply security, engaging with manufacturers, governments and global health institutions to translate access barriers into practical financing structures.

The role combines investment pipeline development with hands-on deal execution, aiming to maintain a prioritized transaction

Responsabilités

• Identify and originate catalytic investment opportunities across CIFF's HIV, TB and SRHR portfolio.
• Develop investment theses for priority diagnostics, pharmaceuticals, devices and partnerships, including access problem and financing gap.
• Assess barriers to product introduction, procurement, manufacturing and market-shaping to unlock faster, affordable scale.
• Design early-stage deal concepts with rationale, demand, instrument and path to execution.
• Build a prioritized pipeline to support 3–5 approvals or launches per year, aligned with strategy.
• Lead transaction execution from concept to due diligence, approvals, contracting and launch.
• Structure investments using recoverable grants, guarantees, debt, equity-like instruments and milestone payments.
• Negotiate terms with manufacturers, investors, DFIs and platforms balancing price and access.
• Coordinate with Legal, Finance and Grants Management to ensure executable, compliant deals.
• Prepare investment papers and analyses outlining strategic fit, impact, risks.

Description du poste

The Senior Manager, SRHR - HIV, TB and Innovative Financing will lead a portfolio of catalytic investment opportunities to improve access, affordability and supply security for priority HIV, TB and SRHR products and delivery models. The role sits at the intersection of strategy, markets and transaction execution, working with manufacturers, procurement platforms, governments, investors and global health institutions to translate access barriers into practical financing structures that support improved health outcomes in low- and middle-income countries. The role combines investment pipeline development with hands-on deal execution, identifying where catalytic capital can address market failures and selecting the financing instruments, partners and commercial terms needed to make investments viable. This may include prefinance facilities, procurement guarantees, working capital facilities, volume commitments, recoverable grants and private sector outcomes funds. The role offers breadth across market shaping, commodity financing, manufacturer partnerships, investment structuring, procurement reform and transition planning across CIFF’s HIV, TB and SRHR portfolio. The role is expected to maintain a prioritised transaction pipeline and take approximately three to five deals from concept to approval or launch annually, with an indicative aggregate value of US$25-50 million, subject to portfolio need, partner readiness and available capital.

Principal Responsibilities

Investment Pipeline Development

• Identify and originate catalytic investment opportunities across CIFF's HIV, TB and SRHR portfolio that can improve access, affordability, supply security and cost-effective scale.
• Develop investment theses for priority diagnostics, pharmaceuticals, devices and manufacturing partnerships, including the access problem, market failure, financing gap, expected impact and CIFF's catalytic role.
• Assess product introduction, procurement, manufacturing, technology transfer and supply-side market-shaping barriers to determine where catalytic investment can unlock faster, more affordable scale.
• Design early-stage deal concepts, including the rationale, partner demand, proposed instrument, expected impact, risk-sharing approach and pathway to execution.
• Build and maintain a prioritised pipeline of investable transactions, with sufficient depth to support approximately three to five approvals or launches per year, subject to strategic fit, additionality, partner demand, execution feasibility and potential to scale beyond CIFF funding.

Deal Execution

• Lead transaction execution for approved investments, from concept refinement and partner engagement with private and public sector partners through due diligence, financial modelling, approvals, contracting, launch and performance monitoring.
• Structure investments using appropriate instruments, including recoverable grants, guarantees, concessional debt, equity-like instruments, milestone-based payments, volume commitments and outcome-linked payments.
• Negotiate commercial terms with manufacturers, investors, DFIs, procurement platforms and delivery partners, balancing price, access, risk allocation, performance milestones, governance and transition arrangements.
• Work with Legal, Finance, Grants Management and programme colleagues to ensure catalytic investment deals are executable, compliant, commercially robust and aligned with CIFF's objectives.
• Prepare investment papers, decision memos and financial analyses that clearly set out strategic fit, expected impact, cost-effectiveness, risks and trade-offs.

Product Access Strategy & Market Shaping

• Work with the Senior Manager, Product Introduction & Market Development to translate product-specific access barriers into investable market-shaping priorities, including registration, demand generation, route to market, procurement readiness, manufacturing capacity and affordability.
• Assess manufacturer economics, supplier constraints, quality assurance pathways, technology transfer requirements and LMIC market-entry barriers to identify where CIFF capital or influence can change access outcomes.
• Define the access conditions that catalytic investment should secure, including price, volume, geography, timelines, supply reliability, quality requirements and commitments to low- and middle-income country availability.
• Engage manufacturers, the Global Fund, regional procurement entities and pooled procurement platforms to understand market dynamics, demand signals and procurement bottlenecks before a transaction is structured.
• Ensure proposed deals support product introduction and market development objectives, rather than operating as standalone financing exercises disconnected from adoption, delivery and long-term scale.
• Capture lessons from priority product access efforts to inform future investment theses, access conditions and market-shaping strategies across the HIV, TB and SRHR portfolio.

Sustainability & Transition

Embed affordability, cos